Search

everythinglearnresearchcommunity

for

Search:↓

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Hair gets thinner, grayer, and changes texture with age due to genetics, environment, and cellular changes, affecting the growth cycle.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.